English

Avantogen Oncology, Inc.

EDGAR

Filing (10QSB) · filed 2007-10-26

50 filing records in this dataset, filed from 1996-08-08 to 2007-10-26. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2004-12-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-585 thousand USD

2004-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -799443 USD Source
Operating Cash Flow: -214237 USD Source

Cash and cash equivalents: 568 thousand USD 2007-06-30 Source
Exact value

567983 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Revenue: 0 USD · 2004-01-01 – 2004-03-31 Source
Revenue: 0 USD · 2004-04-01 – 2004-06-30 Source
Revenue: 0 USD · 2004-07-01 – 2004-09-30 Source
Revenue: 0 USD · 2004-01-01 – 2004-12-31 Source
Revenue: 0 USD · 2004-01-01 – 2004-09-30 Source

Net income

4.16 million USD

2006-07-01 – 2007-06-30

Exact inputs and evidence

Net income: 755250 USD · 2006-07-01 – 2006-09-30 Source
Net income: 5206004 USD · 2006-01-01 – 2006-12-31 Source
Net income: 3472071 USD · 2006-01-01 – 2006-09-30 Source
Net income: 358181 USD · 2007-01-01 – 2007-03-31 Source
Net income: 1309250 USD · 2007-04-01 – 2007-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-10-26.

Financial data available through: 2005-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2005-12-31
Operating income: 2 of 11 periods available· newest 2005-12-31
Net income: 8 of 11 periods available· newest 2005-12-31
Operating cash flow: 8 of 11 periods available· newest 2005-12-31
capital expenditure: No compatible figures in this window
Total assets: 7 of 11 periods available· newest 2005-12-31
Total liabilities: 2 of 11 periods available· newest 2002-12-31
Current assets: 6 of 11 periods available· newest 2005-12-31
Current liabilities: 8 of 11 periods available· newest 2005-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2005-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2004-01-01 – 2004-12-31
Current period

USD 0

2005-01-01 – 2005-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
0 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Avantogen Oncology, Inc. · 2005-12-31 Avantogen Oncology, Inc. (edgar:894538) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-06-015578.txt#2854 Input fundies:Revenue: 0 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-06-015578.txt#2854
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 6.13 million

Prior period

−USD 1.12 million

2004-01-01 – 2004-12-31
Current period

USD 5.01 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

5014506 − -1120037 = 6134543 USD

-1120037 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
5014506 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Avantogen Oncology, Inc. · 2005-12-31 Avantogen Oncology, Inc. (edgar:894538) Year-over-year change in Net income: 6134543 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 5014506 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-07-032307.txt#5261 Input fundies:NetIncome: -1120037 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-06-015578.txt#2955
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.63 million

Prior period

−USD 799,443

2004-01-01 – 2004-12-31
Current period

−USD 2.43 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

-2428846 − -799443 = -1629403 USD

-799443 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
-2428846 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Avantogen Oncology, Inc. · 2005-12-31 Avantogen Oncology, Inc. (edgar:894538) Year-over-year change in Operating cash flow: -1629403 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2428846 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-06-015578.txt#2967 Input fundies:OperatingCashFlow: -799443 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-06-015578.txt#2967
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2005 2005-01-01 – 2005-12-31

Revenue USD 0
Operating costs Derived −USD 4.87 million
Operating income USD 4.87 million
Tax, interest and other Derived −USD 143,285
Net income USD 5.01 million

Cash

Operating cash flow −USD 2.43 million
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	0	Unavailable	Unavailable	Unavailable	0	Unavailable	Source 1995-01-01 – 1995-12-31: 0 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: 0 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: 0 USD Inspect Operating Cash Flow Open source
1996 1996-01-01 – 1996-12-31	0	Unavailable	Unavailable	Unavailable	0	Unavailable	Source 1996-01-01 – 1996-12-31: 0 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: 0 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: 0 USD Inspect Operating Cash Flow Open source
1997 1997-01-01 – 1997-12-31	0	Unavailable	Unavailable	Unavailable	0	Unavailable	Source 1997-01-01 – 1997-12-31: 0 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: 0 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 0 USD Inspect Operating Cash Flow Open source
1998 1998-01-01 – 1998-12-31	0	Unavailable	Unavailable	Unavailable	0	Unavailable	Source 1998-01-01 – 1998-12-31: 0 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 0 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 0 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	137384	Unavailable	Unavailable	Unavailable	-206826	Unavailable	Source 2002-01-01 – 2002-12-31: 137384 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -206826 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 68414 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	6343	Unavailable	Unavailable	Unavailable	-186966	Unavailable	Source 2003-01-01 – 2003-12-31: 6343 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -186966 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -198706 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	0	1112337 Derived	-1112337	7700 Derived	-1120037	Unavailable	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -1112337 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -1120037 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -799443 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	0	-4871221 Derived	4871221	-143285 Derived	5014506	Unavailable	Source 2005-01-01 – 2005-12-31: 0 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 4871221 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 5014506 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -2428846 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2005

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	0	Revenue: 0 Open source
19961996-12-31	Revenue	0	Revenue: 0 Open source
19971997-12-31	Revenue	0	Revenue: 0 Open source
19981998-12-31	Revenue	0	Revenue: 0 Open source
20022002-12-31	Revenue	137384	Revenue: 137384 Open source
20032003-12-31	Revenue	6343	Revenue: 6343 Open source
20042004-12-31	Revenue	0	Revenue: 0 Open source
20052005-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2004

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
19961996-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19971997-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19981998-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 137384 Open source
20032003-12-31	Year over year	-95.4%	Revenue: 6343 Open source Revenue: 137384 Open source
20042004-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 6343 Open source
20052005-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -2,947.6% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Operating margin	Not reported	Revenue: 0 Open source
1996-12-31	Operating margin	Not reported	Revenue: 0 Open source
1997-12-31	Operating margin	Not reported	Revenue: 0 Open source
1998-12-31	Operating margin	Not reported	Revenue: 0 Open source
2002-12-31	Operating margin	Not reported	Revenue: 137384 Open source
2003-12-31	Operating margin	Not reported	Revenue: 6343 Open source
20042004-12-31	Operating margin	Not reported	Operating Income: -1112337 Open source Revenue: 0 Open source
20052005-12-31	Operating margin	Not reported	Operating Income: 4871221 Open source Revenue: 0 Open source
19951995-12-31	Net margin	Not reported	Net Income: 0 Open source Revenue: 0 Open source
19961996-12-31	Net margin	Not reported	Net Income: 0 Open source Revenue: 0 Open source
19971997-12-31	Net margin	Not reported	Net Income: 0 Open source Revenue: 0 Open source
19981998-12-31	Net margin	Not reported	Net Income: 0 Open source Revenue: 0 Open source
20022002-12-31	Net margin	-150.5%	Net Income: -206826 Open source Revenue: 137384 Open source
20032003-12-31	Net margin	-2,947.6%	Net Income: -186966 Open source Revenue: 6343 Open source
20042004-12-31	Net margin	Not reported	Net Income: -1120037 Open source Revenue: 0 Open source
20052005-12-31	Net margin	Not reported	Net Income: 5014506 Open source Revenue: 0 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 137384 Open source Operating Cash Flow: 68414 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 6343 Open source Operating Cash Flow: -198706 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -799443 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2428846 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.4M 2005

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	0	Operating Cash Flow: 0 Open source
19961996-12-31	Operating cash flow	0	Operating Cash Flow: 0 Open source
19971997-12-31	Operating cash flow	0	Operating Cash Flow: 0 Open source
19981998-12-31	Operating cash flow	0	Operating Cash Flow: 0 Open source
20022002-12-31	Operating cash flow	68414	Operating Cash Flow: 68414 Open source
20032003-12-31	Operating cash flow	-198706	Operating Cash Flow: -198706 Open source
20042004-12-31	Operating cash flow	-799443	Operating Cash Flow: -799443 Open source
20052005-12-31	Operating cash flow	-2428846	Operating Cash Flow: -2428846 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
19961996-12-31	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
19971997-12-31	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
19981998-12-31	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: 68414 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -198706 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -799443 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2428846 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

100.5% 1998

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
19981998-12-31	Liabilities / assets	100.5%	Total Liabilities: 1244352 Open source Total Assets: 1237802 Open source
20022002-12-31	Liabilities / assets	Not reported	Total Liabilities: 2681370 Open source Total Assets: 0 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
2004-12-31	Liabilities / assets	Not reported	No source recorded
2005-12-31	Liabilities / assets	Not reported	Total Assets: 1158 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0× 2005

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	Not reported	Current Assets: 0 Open source Current Liabilities: 0 Open source
19961996-12-31	Current assets / current liabilities	Not reported	Current Assets: 0 Open source Current Liabilities: 0 Open source
19971997-12-31	Current assets / current liabilities	Not reported	Current Assets: 0 Open source Current Liabilities: 0 Open source
19981998-12-31	Current assets / current liabilities	Not reported	Current Assets: 0 Open source Current Liabilities: 0 Open source
2002-12-31	Current assets / current liabilities	Not reported	Current Liabilities: 2681370 Open source
2003-12-31	Current assets / current liabilities	Not reported	Current Liabilities: 29943 Open source
20042004-12-31	Current assets / current liabilities	0.04×	Current Assets: 42106 Open source Current Liabilities: 1162143 Open source
20052005-12-31	Current assets / current liabilities	0×	Current Assets: 1158 Open source Current Liabilities: 5404451 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	USD 0 Exact value Exact value: 0 USD 1995-01-01 – 1995-12-31: 0 USD Inspect Net Income Open source Share or cite Citation for Net Income · Avantogen Oncology, Inc. · 1995-12-31 Avantogen Oncology, Inc. (edgar:894538) Net Income: 0 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: 0 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000017188-98-000011.txt#1129 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1995-01-01 – 1995-12-31: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Avantogen Oncology, Inc. · 1995-12-31 Avantogen Oncology, Inc. (edgar:894538) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000017188-98-000011.txt#1138 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	USD 0 Exact value Exact value: 0 USD 1996-01-01 – 1996-12-31: 0 USD Inspect Net Income Open source Share or cite Citation for Net Income · Avantogen Oncology, Inc. · 1996-12-31 Avantogen Oncology, Inc. (edgar:894538) Net Income: 0 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: 0 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000017188-99-000010.txt#1073 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1996-01-01 – 1996-12-31: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Avantogen Oncology, Inc. · 1996-12-31 Avantogen Oncology, Inc. (edgar:894538) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000017188-99-000010.txt#1082 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	USD 0 Exact value Exact value: 0 USD 1997-01-01 – 1997-12-31: 0 USD Inspect Net Income Open source Share or cite Citation for Net Income · Avantogen Oncology, Inc. · 1997-12-31 Avantogen Oncology, Inc. (edgar:894538) Net Income: 0 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 0 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000017188-99-000010.txt#1073 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1997-01-01 – 1997-12-31: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Avantogen Oncology, Inc. · 1997-12-31 Avantogen Oncology, Inc. (edgar:894538) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000017188-99-000010.txt#1082 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	USD 0 Exact value Exact value: 0 USD 1998-01-01 – 1998-12-31: 0 USD Inspect Net Income Open source Share or cite Citation for Net Income · Avantogen Oncology, Inc. · 1998-12-31 Avantogen Oncology, Inc. (edgar:894538) Net Income: 0 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 0 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000017188-99-000010.txt#1073 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1998-01-01 – 1998-12-31: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Avantogen Oncology, Inc. · 1998-12-31 Avantogen Oncology, Inc. (edgar:894538) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000017188-99-000010.txt#1082 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 206,826 Exact value Exact value: -206826 USD 2002-01-01 – 2002-12-31: -206826 USD Inspect Net Income Open source Share or cite Citation for Net Income · Avantogen Oncology, Inc. · 2002-12-31 Avantogen Oncology, Inc. (edgar:894538) Net Income: -206826 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -206826 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000894538-04-000003.txt#931 The citation records this snapshot. The page link may show a newer release later.	USD 68,414 Exact value Exact value: 68414 USD 2002-01-01 – 2002-12-31: 68414 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Avantogen Oncology, Inc. · 2002-12-31 Avantogen Oncology, Inc. (edgar:894538) Operating Cash Flow: 68414 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 68414 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000894538-04-000003.txt#971 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 186,966 Exact value Exact value: -186966 USD 2003-01-01 – 2003-12-31: -186966 USD Inspect Net Income Open source Share or cite Citation for Net Income · Avantogen Oncology, Inc. · 2003-12-31 Avantogen Oncology, Inc. (edgar:894538) Net Income: -186966 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -186966 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000894538-04-000003.txt#931 The citation records this snapshot. The page link may show a newer release later.	−USD 198,706 Exact value Exact value: -198706 USD 2003-01-01 – 2003-12-31: -198706 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Avantogen Oncology, Inc. · 2003-12-31 Avantogen Oncology, Inc. (edgar:894538) Operating Cash Flow: -198706 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -198706 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0000894538-04-000003.txt#971 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 1.12 million Exact value Exact value: -1120037 USD 2004-01-01 – 2004-12-31: -1120037 USD Inspect Net Income Open source Share or cite Citation for Net Income · Avantogen Oncology, Inc. · 2004-12-31 Avantogen Oncology, Inc. (edgar:894538) Net Income: -1120037 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1120037 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-06-015578.txt#2955 The citation records this snapshot. The page link may show a newer release later.	−USD 799,443 Exact value Exact value: -799443 USD 2004-01-01 – 2004-12-31: -799443 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Avantogen Oncology, Inc. · 2004-12-31 Avantogen Oncology, Inc. (edgar:894538) Operating Cash Flow: -799443 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -799443 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-06-015578.txt#2967 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	USD 5.01 million Exact value Exact value: 5014506 USD 2005-01-01 – 2005-12-31: 5014506 USD Inspect Net Income Open source Share or cite Citation for Net Income · Avantogen Oncology, Inc. · 2005-12-31 Avantogen Oncology, Inc. (edgar:894538) Net Income: 5014506 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5014506 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-07-032307.txt#5261 The citation records this snapshot. The page link may show a newer release later.	−USD 2.43 million Exact value Exact value: -2428846 USD 2005-01-01 – 2005-12-31: -2428846 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Avantogen Oncology, Inc. · 2005-12-31 Avantogen Oncology, Inc. (edgar:894538) Operating Cash Flow: -2428846 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T07:56:55Z Snapshot: 0f104a92ea1af22fe1a7dc702d295ced419e12eace38fe41ddabf472edd8ab9e Dimensions: Consolidated View: https://fundies.io/companies/edgar/894538/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2428846 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894538/0001144204-06-015578.txt#2967 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

50 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000894538, 894538, edgar:894538

Also known as FIRST CAPITAL RESOURCES COM INC, HAMPTON BERKSHIRE INSURANCE & FINANCIAL INC, INNOVATE ONCOLOGY, INC., JACKAL INDUSTRIES INC, THERMOVIEW INDUSTRIES INC

Avantogen Oncology, Inc.

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2005 2005-01-01 – 2005-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation